CSL appoints Deborah Waterhouse as CEO as CSL stock costs EUR 121.40
Published on 10/24/2026 at 10:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSLeadership transition and trading date
- CSL announced Deborah Waterhouse as chief executive on October 21, 2026.
- CSL stock trades in weekend trading at Lang & Schwarz at EUR 121.40 at 10:15 a.m. CEST on October 24, 2026.
- The next Xetra session is scheduled for October 26, 2026.
CSL Limited announced on October 21, 2026, that its board had appointed Deborah Waterhouse as chief executive officer and managing director from February 1, 2027, according to the company’s announcement.
Waterhouse is to succeed Interim CEO and Managing Director Gordon Naylor, who will resume his role as a non-executive director. The company said Waterhouse has led ViiV Healthcare since 2017 and will retain her base in the United Kingdom.
At 10:15 a.m. CEST on October 24, 2026, CSL stock trades in weekend trading at Lang & Schwarz at EUR 121.40. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of CSL stock.
Recent company developments
In a separate October 22, 2026 ASX announcement, CSL said it would defend a group proceeding filed in the Supreme Court of Victoria. The company said it denies liability and will vigorously defend the proceeding, according to the ASX announcement.
CSL’s next Xetra session is scheduled for October 26, 2026. Market context: Market report S&P/ASX 200.
